Community-acquired In this review, we examine the existing evidence that pertains to the use of dual-action agents in the symptomatic management of allergic conjunctivitis. Allergic conjunctivitis is an allergic condition of the eye that usually presents with itching, redness, swelling of eyelids, tearing, and ocular discharge. The data used to collate this review were obtained from various peer-reviewed journal articles on the dual-action drugs and their role in managing allergic conjunctivitis, PubMed using relevant MeSH terms, and also in Scopus and Google Scholar using relevant keywords All the dual-acting agents and their rising role of in the management of allergic conjunctivitis were examined and included. Opinions from practicing ophthalmologists were also incorporated in writing the review. On assessing the available literature on the various treatment strategies, the use and recommendation of dual-action agents are more frequent and effective for managing the symptoms of Allergic conjunctivitis. Dual Action Agents are recommended more as they are superior in ameliorating the ocular symptoms associate with AC rapidly and their actions persist for a longer duration. From this review, it was established that the use of dual-action agents such as olopatadine, Bepotastine Besilate, and Alcaftadine are on the rise as they provide rapid relief from ocular symptoms. Various treatment strategies are also discussed in view of identifying the popularity of Dual Acting Agents. © 2022 Elsevier B.V., All rights reserved.